PT - JOURNAL ARTICLE AU - Ioannis Karampinis AU - Georgia Hardavella AU - Theodore Mariolis AU - Antonios Katsipoulakis AU - Nikolaos Anastasiou TI - New era in Oesophageal surgery; the art of combining sweet and sour flavours AID - 10.1183/13993003.congress-2020.1725 DP - 2020 Sep 07 TA - European Respiratory Journal PG - 1725 VI - 56 IP - suppl 64 4099 - http://erj.ersjournals.com/content/56/suppl_64/1725.short 4100 - http://erj.ersjournals.com/content/56/suppl_64/1725.full SO - Eur Respir J2020 Sep 07; 56 AB - Method: Oesophageal surgery is complex and is mainly performed in highly specialised centres with enhanced multidisciplinary input. The most widely accepted oesophagectomy techniques are the Ivor Lewis and the Sweet approach.Aim: To assess and compare the clinical effectiveness, clinical outcomes and 2 year survival in patients who underwent oesophagectomy with either procedure for oesophageal cancer.Materials and Methods: Retrospective review of all patients who underwent oesophagectomy between 2001-2018 (Sweet approach 36 patients, Ivor Lewis 31). Review of medical records and electronic databases.Results: During 2001-2018, 36 male patients underwent oesophagectomy with left thoracophrenotomy for cancers of mid and lower oesophagus (group I) and 31 patients underwent abdominal incision and a right thoracotomy (Ivor Lewis)(group II). Mean age was 68 years (age range 29-84 years). Mean theatre time for group I was 240 mins and mean hospital stay was 9 days whereas for group II were 310 mins and 11.7 days respectively. There was only 1 hospital death in gr.I (due to Klebsiella pneumoniae infection) and 4 deaths in gr II (mainly due to pulmonary embolism). Morbidity was 21% (including cardiovascular, respiratory and multifactorial entities) and 2-year overall survival was 85% (group I) and 77% (group II).Conclusions: The Sweet approach carries less intraoperative time, less mortality and less hospital stay than the Ivor Lewis approach and it is considered an effective approach in modern Thoracic Surgery.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1725.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).